SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-15-388749
Filing Date
2015-11-25
Accepted
2015-11-25 16:16:00
Documents
3
Group Members
KEN TAKANASHISNBL USA, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D d17006dsc13d.htm SC 13D 73335
2 EX-99.1 d17006dex991.htm EX-99.1 6481
3 EX-99.3 d17006dex993.htm EX-99.3 32185
  Complete submission text file 0001193125-15-388749.txt   113806
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89180 | Film No.: 151256375
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394
Business Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394 81-99-294-2600
Shin Nippon Biomedical Laboratories, Ltd. (Filed by) CIK: 0001657770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC 13D